Meléndez-Alafort L - Search Results

1

In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy.

Allen KJH, Frank C, Jiao R, Malo ME, Bello M, De Nardo L, Meléndez-Alafort L, Dadachova E. Allen KJH, et al. Among authors: melendez alafort l. ACS Omega. 2024 Dec 4;9(50):50000-50011. doi: 10.1021/acsomega.4c09450. eCollection 2024 Dec 17. ACS Omega. 2024. PMID: 39713652 Free PMC article.

2

Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced ^99m Tc.

Meléndez-Alafort L, Ferro-Flores G, De Nardo L, Bello M, Paiusco M, Negri A, Zorz A, Uzunov N, Esposito J, Rosato A. Meléndez-Alafort L, et al. Med Phys. 2019 Mar;46(3):1437-1446. doi: 10.1002/mp.13393. Epub 2019 Feb 8. Med Phys. 2019. PMID: 30661241

3

Development of ¹⁷⁷Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen.

Carpanese D, Ferro-Flores G, Ocampo-Garcia B, Santos-Cuevas C, Salvarese N, Figini M, Fracasso G, De Nardo L, Bolzati C, Rosato A, Meléndez-Alafort L. Carpanese D, et al. Sci Rep. 2020 Jun 9;10(1):9313. doi: 10.1038/s41598-020-66285-2. Sci Rep. 2020. PMID: 32518372 Free PMC article.

4

Preclinical dosimetric studies of ¹⁷⁷ Lu-scFvD2B and comparison with ¹⁷⁷ Lu-PSMA-617 and ¹⁷⁷ Lu-iPSMA endoradiotherapeutic agents.

Meléndez-Alafort L, Ferro-Flores G, Santos-Cuevas C, Ocampo-García B, Turato S, Fracasso G, Bolzati C, Rosato A, De Nardo L. Meléndez-Alafort L, et al. Med Phys. 2021 Jul;48(7):4064-4074. doi: 10.1002/mp.14936. Epub 2021 Jun 7. Med Phys. 2021. PMID: 33966284

5

A feasibility study of the therapeutic application of a mixture of ^67/64 Cu radioisotopes produced by cyclotrons with proton irradiation.

De Nardo L, Pupillo G, Mou L, Esposito J, Rosato A, Meléndez-Alafort L. De Nardo L, et al. Med Phys. 2022 Apr;49(4):2709-2724. doi: 10.1002/mp.15524. Epub 2022 Feb 20. Med Phys. 2022. PMID: 35134261 Free PMC article.

6

Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations.

Salvarese N, Carpanese D, Meléndez-Alafort L, De Nardo L, Calderan A, Biondi B, Ruzza P, Rosato A, Bolzati C. Salvarese N, et al. Molecules. 2022 Apr 14;27(8):2548. doi: 10.3390/molecules27082548. Molecules. 2022. PMID: 35458745 Free PMC article.

7

²²⁵Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins.

Hernández-Jiménez T, Ferro-Flores G, Morales-Ávila E, Isaac-Olivé K, Ocampo-García B, Aranda-Lara L, Santos-Cuevas C, Luna-Gutiérrez M, De Nardo L, Rosato A, Meléndez-Alafort L. Hernández-Jiménez T, et al. Molecules. 2022 Mar 27;27(7):2156. doi: 10.3390/molecules27072156. Molecules. 2022. PMID: 35408554 Free PMC article.

8

Comparison of the dosimetry and cell survival effect of ¹⁷⁷Lu and ¹⁶¹Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases.

De Nardo L, Santi S, Dalla Pietà A, Ferro-Flores G, Azorín-Vega E, Nascimbene E, Barbieri V, Zorz A, Rosato A, Meléndez-Alafort L. De Nardo L, et al. Among authors: melendez alafort l. EJNMMI Phys. 2024 Nov 13;11(1):94. doi: 10.1186/s40658-024-00696-2. EJNMMI Phys. 2024. PMID: 39535653 Free PMC article.

9

Radiation effective dose assessment of [⁵¹Mn]- and [⁵²Mn]-chloride.

De Nardo L, Ferro-Flores G, Bolzati C, Esposito J, Meléndez-Alafort L. De Nardo L, et al. Appl Radiat Isot. 2019 Nov;153:108805. doi: 10.1016/j.apradiso.2019.108805. Epub 2019 Jul 11. Appl Radiat Isot. 2019. PMID: 31382087

10

Nuclear Cross-Section of Proton-Induced Reactions on Enriched ⁴⁸Ti Targets for the Production of Theranostic ⁴⁷Sc Radionuclide, ^46cSc, ^44mSc, ^44gSc, ⁴³Sc, and ⁴⁸V.

Mou L, De Dominicis L, Cisternino S, Skliarova H, Campostrini M, Rigato V, De Nardo L, Meléndez-Alafort L, Esposito J, Haddad F, Pupillo G. Mou L, et al. Among authors: melendez alafort l. Pharmaceuticals (Basel). 2023 Dec 23;17(1):26. doi: 10.3390/ph17010026. Pharmaceuticals (Basel). 2023. PMID: 38256860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters